Astellas Pharma Inc. - Depreciation

Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Depreciation" stands at 196.67 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025.

Astellas Pharma Inc.'s first quarter result of 47.80 Billion JPY for the item "Depreciation" represents an increase of 0.25 percent compared to it's fourth quarter result of the company's last fiscal year.

Also, Astellas Pharma Inc.'s first quarter result of 47.80 Billion JPY for the item "Depreciation" represents a decrease of -4.90 percent compared to it's first quarter result of last year.

Looking again at the trailing twelve months series (TTM), Astellas Pharma Inc.'s first quarter result of 196.67 Billion JPY for the item "Depreciation" represents a decrease of -1.24 percent compared to it's fourth quarter result of the company's last fiscal year.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 6.39 percent compared to the value the year prior.
The 1 year change in percent is 6.39.
The 3 year change in percent is 99.84.
The 5 year change in percent is 191.87.
The 10 year change in percent is 191.81.

The Serie's long term average value is 83.27 Billion Japanese Yens. It's latest available value, on 06/30/2025, is 136.18 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2013, to it's latest available value, on 06/30/2025, is +1,154.58%.
The Serie's change in percent from it's maximum value, on 12/31/2024, to it's latest available value, on 06/30/2025, is -1.71%.